Pulse Biosciences Inc Asset Resilience Ratio
Pulse Biosciences Inc asset resilience ratio. Pulse Biosciences Inc (PLSE) has an Asset Resilience Ratio of 0.00% as of December 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Pulse Biosciences Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Pulse Biosciences Inc (2015–2021)
Asset resilience ratio of Pulse Biosciences Inc from 2015 to 2021. This chart shows how Pulse Biosciences Inc's Asset Resilience Ratio has changed over time. Read total liabilities of Pulse Biosciences Inc for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Pulse Biosciences Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Pulse Biosciences Inc's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Pulse Biosciences Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Pulse Biosciences Inc Industry Peers by Asset Resilience Ratio
Compare Pulse Biosciences Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Caina Technology Co. Ltd.
SHE:301122 |
Medical Instruments & Supplies | 19.55% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
Ocumetics Technology Corp
V:OTC |
Medical Instruments & Supplies | 0.00% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
Pulse Biosciences Inc Asset Resilience Ratio by Year (2015–2021)
Pulse Biosciences Inc asset resilience ratio by year from 2015 to 2021. The table below shows the annual Asset Resilience Ratio data for Pulse Biosciences Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 0.00% | $0.00 | $54.25 Million | -- |
| 2020-12-31 | 19.40% | $8.01 Million | $41.29 Million | -24.73pp |
| 2019-12-31 | 44.13% | $18.50 Million | $41.91 Million | +32.13pp |
| 2018-12-31 | 12.00% | $8.48 Million | $70.64 Million | -57.61pp |
| 2017-12-31 | 69.62% | $34.68 Million | $49.82 Million | +15.25pp |
| 2016-12-31 | 54.37% | $14.31 Million | $26.31 Million | -45.50pp |
| 2015-12-31 | 99.87% | $14.31 Million | $14.33 Million | -- |
About Pulse Biosciences Inc
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac… Read more